Is Cypherpunk Technologies Inc. (CYPH) a Buy, Sell, or Hold?
NASDAQ : CYPH
Cypherpunk Technologies Inc. — News
$0.6579 USD
-$0.02 (-3.25%)
- Volume
- 1.84M
- Average Volume
- 3.81M
- Market Capitalization
- $70.04M
- P/E Ratio
- 1.04
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $3.70
- Year Low
- $0.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $79.19
| Source | Headline |
|---|---|
|
Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026. prnewswire.com - 2026-08-12 07:05:00 |
|
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
Peer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab and chemotherapy CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Leap Therapeutics, Inc., the biotechnology subsidiary of Cypherpunk Technologies Inc. (Nasdaq: CYPH), today announced the publication of results from the randomized Phase 2 DeFianCe study of sirexatamab (DKN-01), an anti-DKK1 monoclonal antibody, in Clinical Cancer Research. prnewswire.com - 2026-08-12 07:00:00 |
|
Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript
Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript seekingalpha.com - 2026-06-18 12:32:09 |
|
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026. prnewswire.com - 2026-05-14 07:05:00 |
